NuvemRx, a 340B pharmacy solutions and technology company, this week announced that it has acquired a 340B referral capture business, [...] …
Blog Posts
Providers navigating the Inflation Reduction Act’s (IRA) rollout say they are growing concerned about the lack of transparency into how [...] …
Drugmaker Eli Lilly defended its newly implemented policy requiring covered entities to report 340B claims data for in-house pharmacy utilization [...] …
SPONSORED CONTENT
Covered entities (CEs) are facing a period of rapid change, making adaptability and strategic planning more important than ever.
In 2025, the 340B program experienced major turbulence:
- HRSA’s 340B Rebate Pilot
The Health Resources and Services Administration (HRSA) informed 340B stakeholders this week that the staff in its Office of Pharmacy [...] …
Attorneys representing 44 health systems and the Health Resources and Services Administration (HRSA) squared off over a contentious federal 340B [...] …
State lawmakers in Michigan and Virginia recently voted to advance bills that would prohibit drug manufacturers from placing 340B contract [...] …
Two drugmakers recently updated their 340B contract pharmacy restriction policies—one to exempt new states that have enacted contract pharmacy access [...] …
An influential U.S. Senate Republican and longtime 340B critic has expanded his yearslong inquiry into the 340B program to include [...] …
The U.S. Senate continued negotiations Thursday on a series of House-passed federal spending bills, putting the fate of a bipartisan-backed [...] …










